Published in PLoS Pathog on February 26, 2010
Coupling viruses to dynein and kinesin-1. EMBO J (2011) 1.83
Arl8 and SKIP act together to link lysosomes to kinesin-1. Dev Cell (2011) 1.37
Structural basis for kinesin-1:cargo recognition. Science (2013) 0.97
A kinesin-1 binding motif in vaccinia virus that is widespread throughout the human genome. EMBO J (2011) 0.96
The taking of the cytoskeleton one two three: how viruses utilize the cytoskeleton during egress. Virology (2011) 0.88
Adenovirus recruits dynein by an evolutionary novel mechanism involving direct binding to pH-primed hexon. Viruses (2011) 0.88
A36-dependent actin filament nucleation promotes release of vaccinia virus. PLoS Pathog (2013) 0.85
Loss of cytoskeletal transport during egress critically attenuates ectromelia virus infection in vivo. J Virol (2012) 0.82
Orthopoxvirus targets for the development of new antiviral agents. Antiviral Res (2012) 0.81
Prediction of steps in the evolution of variola virus host range. PLoS One (2014) 0.80
Modulation of the myxoma virus plaque phenotype by vaccinia virus protein F11. J Virol (2012) 0.80
Trichoplusia ni Kinesin-1 Associates with Autographa californica Multiple Nucleopolyhedrovirus Nucleocapsid Proteins and Is Required for Production of Budded Virus. J Virol (2016) 0.78
Chordopoxvirus protein F12 implicated in enveloped virion morphogenesis is an inactivated DNA polymerase. Biol Direct (2014) 0.77
Vaccinia virus protein complex F12/E2 interacts with kinesin light chain isoform 2 to engage the kinesin-1 motor complex. PLoS Pathog (2015) 0.76
Vaccinia Virus Proteins A36 and F12/E2 Show Strong Preferences for Different KLC Isoforms. Traffic (2017) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics (2009) 31.84
WHAT IF: a molecular modeling and drug design program. J Mol Graph (1990) 24.35
Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct (2000) 17.81
Multiple sequence alignment with Clustal X. Trends Biochem Sci (1998) 15.10
Assessment of protein models with three-dimensional profiles. Nature (1992) 12.64
Main-chain bond lengths and bond angles in protein structures. J Mol Biol (1993) 9.80
TPR proteins: the versatile helix. Trends Biochem Sci (2003) 7.37
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol (1994) 4.67
Molecular motors and mechanisms of directional transport in neurons. Nat Rev Neurosci (2005) 4.46
The formation and function of extracellular enveloped vaccinia virus. J Gen Virol (2002) 4.14
Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques (1997) 3.74
Vaccinia as a model for membrane biogenesis. Virology (1968) 3.73
Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus. Nat Cell Biol (2001) 3.67
Biogenesis of poxviruses: role of A-type inclusions and host cell membranes in virus dissemination. Virology (1971) 3.57
Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes. Eur J Cell Biol (1993) 3.46
Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling. Nature (1999) 3.44
Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J Virol (1985) 3.44
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell (1992) 3.36
In a nutshell: structure and assembly of the vaccinia virion. Adv Virus Res (2006) 3.17
Vaccinia virus reexamined: development and release. Virology (1976) 3.15
Kinesin-dependent axonal transport is mediated by the sunday driver (SYD) protein. Cell (2000) 2.96
Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I. Neuron (2000) 2.94
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology (1994) 2.89
A monoclonal antibody against kinesin inhibits both anterograde and retrograde fast axonal transport in squid axoplasm. Proc Natl Acad Sci U S A (1990) 2.89
A complex of N-WASP and WIP integrates signalling cascades that lead to actin polymerization. Nat Cell Biol (2000) 2.72
Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J (2002) 2.70
SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus. Science (2004) 2.44
Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases. Nat Med (2005) 2.43
Cargo transport: molecular motors navigate a complex cytoskeleton. Curr Opin Cell Biol (2008) 2.39
Mechanism of vaccinia virus release and its specific inhibition by N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine. J Virol (1979) 2.33
Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol (2001) 2.10
Kinesin-1 structural organization and conformational changes revealed by FRET stoichiometry in live cells. J Cell Biol (2007) 2.08
Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem (2005) 1.98
Vaccinia virus intracellular movement is associated with microtubules and independent of actin tails. J Virol (2001) 1.87
Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J Gen Virol (1998) 1.81
Tubulin and CRMP-2 complex is transported via Kinesin-1. J Neurochem (2005) 1.80
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol (2007) 1.73
Vaccinia virus morphogenesis and dissemination. Trends Microbiol (2008) 1.73
Immunochemical analysis of kinesin light chain function. Mol Biol Cell (1997) 1.72
Grb2 and Nck act cooperatively to promote actin-based motility of vaccinia virus. Curr Biol (2002) 1.71
A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J (2004) 1.71
Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol (2005) 1.70
Role for the vaccinia virus A36R outer envelope protein in the formation of virus-tipped actin-containing microvilli and cell-to-cell virus spread. Virology (1998) 1.68
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
The Drosophila kinesin light chain. Primary structure and interaction with kinesin heavy chain. J Biol Chem (1993) 1.60
Tyrosine phosphorylation is required for actin-based motility of vaccinia but not Listeria or Shigella. Curr Biol (1999) 1.57
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog (2008) 1.57
The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology (2000) 1.56
The novel cargo Alcadein induces vesicle association of kinesin-1 motor components and activates axonal transport. EMBO J (2007) 1.55
The Salmonella effector protein PipB2 is a linker for kinesin-1. Proc Natl Acad Sci U S A (2006) 1.54
The rate of N-WASP exchange limits the extent of ARP2/3-complex-dependent actin-based motility. Nature (2009) 1.53
Calsyntenin-1 docks vesicular cargo to kinesin-1. Mol Biol Cell (2006) 1.53
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J Gen Virol (2000) 1.52
Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein. J Gen Virol (2001) 1.51
Review: regulation mechanisms of Kinesin-1. J Muscle Res Cell Motil (2006) 1.41
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol (2000) 1.38
The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol (2002) 1.38
Visualization and characterization of the intracellular movement of vaccinia virus intracellular mature virions. J Virol (2005) 1.35
Vaccinia virus cores are transported on microtubules. J Gen Virol (2003) 1.33
Tetratrico peptide repeats are present in the kinesin light chain. Trends Biochem Sci (1996) 1.28
Co-operative versus independent transport of different cargoes by Kinesin-1. Traffic (2008) 1.24
Cargo selection by specific kinesin light chain 1 isoforms. EMBO J (2006) 1.21
The early onset dystonia protein torsinA interacts with kinesin light chain 1. J Biol Chem (2004) 1.16
Trafficking of signaling modules by kinesin motors. J Cell Sci (2003) 1.16
Vaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesin. J Virol (2004) 1.12
The release of vaccinia virus from infected cells requires RhoA-mDia modulation of cortical actin. Cell Host Microbe (2007) 1.12
Kidins220/ARMS is transported by a kinesin-1-based mechanism likely to be involved in neuronal differentiation. Mol Biol Cell (2006) 1.05
Phosphorylation-dependent interaction of kinesin light chain 2 and the 14-3-3 protein. Biochemistry (2002) 1.05
Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. J Gen Virol (2005) 0.95
An E2-F12 complex is required for intracellular enveloped virus morphogenesis during vaccinia infection. Cell Microbiol (2009) 0.94
Vaccinia virus protein F12 associates with intracellular enveloped virions through an interaction with A36. J Virol (2008) 0.92
Cayman ataxia protein caytaxin is transported by kinesin along neurites through binding to kinesin light chains. J Cell Sci (2009) 0.92
Jump-starting kinesin. J Cell Biol (2007) 0.92
Vaccinia virus E2L null mutants exhibit a major reduction in extracellular virion formation and virus spread. J Virol (2008) 0.91
Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails. J Gen Virol (2004) 0.86
Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor. EMBO J (1992) 0.85
Insertional inactivation of a fowlpox virus homologue of the vaccinia virus F12L gene inhibits the release of enveloped virions. J Gen Virol (1993) 0.85
HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med (2004) 5.08
Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans. Nat Med (2003) 4.64
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J Exp Med (2003) 2.85
Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med (2005) 2.66
Poxvirus genomes: a phylogenetic analysis. J Gen Virol (2004) 2.40
Vaccinia virus motility. Annu Rev Microbiol (2003) 1.88
Genome sequence diversity and clues to the evolution of variola (smallpox) virus. Science (2006) 1.84
Endocytic tubules regulated by Rab GTPases 5 and 11 are used for envelopment of herpes simplex virus. EMBO J (2012) 1.75
Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol (2007) 1.73
Vaccinia virus morphogenesis and dissemination. Trends Microbiol (2008) 1.73
Entry of the vaccinia virus intracellular mature virion and its interactions with glycosaminoglycans. J Gen Virol (2005) 1.70
Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination. Nat Med (2006) 1.64
Inhibition of IkappaB kinase by vaccinia virus virulence factor B14. PLoS Pathog (2008) 1.63
Ligand-induced and nonfusogenic dissolution of a viral membrane. Proc Natl Acad Sci U S A (2006) 1.62
Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J Gen Virol (2002) 1.59
Vaccinia virus proteins A52 and B14 Share a Bcl-2-like fold but have evolved to inhibit NF-kappaB rather than apoptosis. PLoS Pathog (2008) 1.57
The vaccinia virus N1L protein is an intracellular homodimer that promotes virulence. J Gen Virol (2002) 1.57
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife (2012) 1.53
Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol (2005) 1.52
Role of the intracellular domains of CXCR4 in SDF-1-mediated signaling. Blood (2002) 1.45
The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses. Infect Immun (2002) 1.45
An investigation of the therapeutic value of vaccinia-immune IgG in a mouse pneumonia model. J Gen Virol (2005) 1.45
A kinetic analysis of immune mediators in the lungs of mice infected with vaccinia virus and comparison with intradermal infection. J Gen Virol (2003) 1.43
Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity. J Gen Virol (2013) 1.41
The vaccinia virus F12L protein is associated with intracellular enveloped virus particles and is required for their egress to the cell surface. J Gen Virol (2002) 1.38
Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes. J Gen Virol (2002) 1.36
Vaccinia virus interleukin-18-binding protein promotes virulence by reducing gamma interferon production and natural killer and T-cell activity. J Virol (2003) 1.34
The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J Gen Virol (2002) 1.33
Vaccinia virus cores are transported on microtubules. J Gen Virol (2003) 1.33
A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence. J Gen Virol (2002) 1.30
Deletion of gene A41L enhances vaccinia virus immunogenicity and vaccine efficacy. J Gen Virol (2006) 1.25
The TNFR family members OX40 and CD27 link viral virulence to protective T cell vaccines in mice. J Clin Invest (2010) 1.24
Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7. PLoS Pathog (2011) 1.22
Steroid hormone synthesis by vaccinia virus suppresses the inflammatory response to infection. J Exp Med (2003) 1.19
Fixation-induced redistribution of hyperphosphorylated RNA polymerase II in the nucleus of human cells. Exp Cell Res (2004) 1.19
A new inhibitor of apoptosis from vaccinia virus and eukaryotes. PLoS Pathog (2007) 1.17
Vaccinia virus strain Western Reserve protein B14 is an intracellular virulence factor. J Gen Virol (2006) 1.14
The zebrafish as a new model for the in vivo study of Shigella flexneri interaction with phagocytes and bacterial autophagy. PLoS Pathog (2013) 1.12
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy. J Gen Virol (2005) 1.12
How vaccinia virus has evolved to subvert the host immune response. J Struct Biol (2011) 1.11
The vaccinia virus C12L protein inhibits mouse IL-18 and promotes virus virulence in the murine intranasal model. J Gen Virol (2002) 1.10
Poxvirus targeting of E3 ligase β-TrCP by molecular mimicry: a mechanism to inhibit NF-κB activation and promote immune evasion and virulence. PLoS Pathog (2013) 1.08
Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A (2007) 1.08
The vaccinia virus kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. J Gen Virol (2003) 1.07
Intradermal immune response after infection with Vaccinia virus. J Gen Virol (2006) 1.06
An investigation of incorporation of cellular antigens into vaccinia virus particles. J Gen Virol (2002) 1.05
Structure and function of A41, a vaccinia virus chemokine binding protein. PLoS Pathog (2008) 1.04
Structure of CrmE, a virus-encoded tumour necrosis factor receptor. J Mol Biol (2007) 1.03
Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax. J Gen Virol (2008) 1.01
PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci U S A (2009) 1.01
Inhibition of the RNA polymerase III-mediated dsDNA-sensing pathway of innate immunity by vaccinia virus protein E3. J Gen Virol (2010) 1.00
Inhibition of apoptosis and NF-κB activation by vaccinia protein N1 occur via distinct binding surfaces and make different contributions to virulence. PLoS Pathog (2011) 1.00
The vaccinia virus soluble interferon-gamma receptor is a homodimer. J Gen Virol (2002) 0.99
Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist. J Biol Chem (2006) 0.99
Vaccinia virus CrmE encodes a soluble and cell surface tumor necrosis factor receptor that contributes to virus virulence. Virology (2002) 0.98
A soluble chemokine-binding protein from vaccinia virus reduces virus virulence and the inflammatory response to infection. J Immunol (2003) 0.98
Vaccinia virus protein C4 inhibits NF-κB activation and promotes virus virulence. J Gen Virol (2012) 0.97
Mapping the IkappaB kinase beta (IKKbeta)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKbeta-mediated activation of nuclear factor kappaB. J Biol Chem (2011) 0.97
Vaccinia virus intracellular enveloped virions move to the cell periphery on microtubules in the absence of the A36R protein. J Gen Virol (2005) 0.95
Clathrin-mediated endocytosis and subsequent endo-lysosomal trafficking of adeno-associated virus/phage. J Biol Chem (2012) 0.94
Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus. Methods Mol Biol (2004) 0.94
Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence. J Gen Virol (2007) 0.93
B and CTL responses to the ALK protein in patients with ALK-positive ALCL. Int J Cancer (2006) 0.93
Vaccinia virus kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model. J Gen Virol (2006) 0.92
Vaccinia virus protein N2 is a nuclear IRF3 inhibitor that promotes virulence. J Gen Virol (2013) 0.90
Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts. J Virol (2009) 0.90
Six-transmembrane topology for Golgi anti-apoptotic protein (GAAP) and Bax inhibitor 1 (BI-1) provides model for the transmembrane Bax inhibitor-containing motif (TMBIM) family. J Biol Chem (2012) 0.90
Rab6 dependent post-Golgi trafficking of HSV1 envelope proteins to sites of virus envelopment. Traffic (2013) 0.89
Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response. J Gen Virol (2007) 0.89
Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence. J Gen Virol (2008) 0.89
A mechanism for the inhibition of DNA-PK-mediated DNA sensing by a virus. PLoS Pathog (2013) 0.88
Acidic residues in the membrane-proximal stalk region of vaccinia virus protein B5 are required for glycosaminoglycan-mediated disruption of the extracellular enveloped virus outer membrane. J Gen Virol (2009) 0.88
Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes. J Immunol (2010) 0.87
Improved expression of secreted and membrane-targeted proteins in insect cells. Biotechnol Appl Biochem (2010) 0.87
Vaccinia virus protein K7 is a virulence factor that alters the acute immune response to infection. J Gen Virol (2013) 0.86
A new member of the interleukin 10-related cytokine family encoded by a poxvirus. J Gen Virol (2004) 0.86
Vaccinia virus lacking the Bcl-2-like protein N1 induces a stronger natural killer cell response to infection. J Gen Virol (2008) 0.86
Deletion of immunomodulator C6 from vaccinia virus strain Western Reserve enhances virus immunogenicity and vaccine efficacy. J Gen Virol (2013) 0.86
Yaba-like disease virus protein Y144R, a member of the complement control protein family, is present on enveloped virions that are associated with virus-induced actin tails. J Gen Virol (2004) 0.86
Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface. J Gen Virol (2002) 0.85
The vaccinia virus B9R protein is a 6 kDa intracellular protein that is non-essential for virus replication and virulence. J Gen Virol (2002) 0.85
Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation. J Virol (2013) 0.85
A mechanism for induction of a hypoxic response by vaccinia virus. Proc Natl Acad Sci U S A (2013) 0.84